SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-18-002600
Filing Date
2018-03-15
Accepted
2018-03-15 16:11:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO REGISTRATION STATEMENT gtbp_s3.htm S-3/A 489447
  Complete submission text file 0001654954-18-002600.txt   490733
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-223348 | Film No.: 18692481
SIC: 2834 Pharmaceutical Preparations